Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding low-dose atropine for myopia progression in European children
2024-516758-23-00Phase 2Completed
- Sponsor
- Pharma Stulln
- Start
- Sep 2024
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of atropine in myopia (5 arms), sponsored by Pharma Stulln. Primary endpoint: Change in myopia (spherical equivalent) over 12 months. Started Sep 2024; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on 2024-516758-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516758-23-00.